Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
November-2016 Volume 36 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2016 Volume 36 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review

Depression accelerates the development of gastric cancer through reactive oxygen species‑activated ABL1 (Review)

  • Authors:
    • Tianhe Huang
    • Fuling Zhou
    • Feng Wang‑Johanning
    • Kejun Nan
    • Yongchang Wei
  • View Affiliations / Copyright

    Affiliations: Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Department of Clinical Hematology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei 430071, P.R. China, Viral Oncology Program, SRI International, Menlo Park, CA 94025, USA
  • Pages: 2435-2443
    |
    Published online on: September 23, 2016
       https://doi.org/10.3892/or.2016.5127
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Depression is a common symptom among gastric cancer (GC) patients and serves as a potential indication of poor prognosis and advanced cancer clinical stage. However, the molecular mechanism of depression‑associated poor prognoses of GC patients remains unclear. Recent studies have revealed that GC patients with depression are under high levels of oxidative stress (OS) status that is accompanied by the dysfunction of numerous proto‑oncogenes, including the ABL proto‑oncogene 1 (ABL1), which is a non‑receptor tyrosine kinase. Recent evidence indicates that ABL1 was dysregulated in both major depressive disorder (MDD) and cancer patients with depression, and high levels of reactive oxygen species (ROS) can lead to the activation of ABL1 in response to OS and that activated ABL1 subsequently contributes to development of GC via interactions with the downstream targets and corresponding signaling pathways. In this review, we examine the evidence to illuminate the molecular mechanism of ABL1 in the progression of GC patients with depression and identify out new and effective methods for the initial and long‑term treatment of GC.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Riquelme I, Saavedra K, Espinoza JA, Weber H, García P, Nervi B, Garrido M, Corvalán AH, Roa JC and Bizama C: Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. Oncotarget. 6:24750–24779. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Hong JS and Tian J: Prevalence of anxiety and depression and their risk factors in Chinese cancer patients. Support Care Cancer. 22:453–459. 2014. View Article : Google Scholar

3 

Delgado-Guay M, Ferrer J, Rieber AG, Rhondali W, Tayjasanant S, Ochoa J, Cantu H, Chisholm G, Williams J, Frisbee-Hume S, et al: Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients. Oncologist. 20:1092–1098. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Walker J, Hansen CH, Martin P, Symeonides S, Gourley C, Wall L, Weller D, Murray G and Sharpe M; SMaRT (Symptom Management Research Trials) Oncology-3 Team: Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): A multicentre randomised controlled trial in patients with lung cancer. Lancet Oncol. 15:1168–1176. 2014. View Article : Google Scholar : PubMed/NCBI

5 

Andersen BL, DeRubeis RJ, Berman BS, Gruman J, Champion VL, Massie MJ, Holland JC, Partridge AH, Bak K, Somerfield MR, et al American Society of Clinical Oncology: Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 32:1605–1619. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Jiménez-Fernández S, Gurpegui M, Díaz-Atienza F, Pérez-Costillas L, Gerstenberg M and Correll CU: Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: Results from a meta-analysis. J Clin Psychiatry. 76:1658–1667. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Hermes-Lima M, Moreira DC, Rivera-Ingraham GA, Giraud-Billoud M, Genaro-Mattos TC and Campos EG: Preparation for oxidative stress under hypoxia and metabolic depression: Revisiting the proposal two decades later. Free Radic Biol Med. 89:1122–1143. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Chaturvedi R, de Sablet T, Asim M, Piazuelo MB, Barry DP, Verriere TG, Sierra JC, Hardbower DM, Delgado AG, Schneider BG, et al: Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase. Oncogene. 34:3429–3440. 2015. View Article : Google Scholar :

9 

Warsch W, Grundschober E, Berger A, Gille L, Cerny-Reiterer S, Tigan AS, Hoelbl-Kovacic A, Valent P, Moriggl R and Sexl V: STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia. Oncotarget. 3:1669–1687. 2012. View Article : Google Scholar

10 

No authors listed. FH-deficient cancers depend on ABL1-mediated metabolic adaptation. Cancer Discov. 5:OF92015. View Article : Google Scholar

11 

Wang JY: The capable ABL: What is its biological function? Mol Cell Biol. 34:1188–1197. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Yi Z, Li Z, Yu S, Yuan C, Hong W, Wang Z, Cui J, Shi T and Fang Y: Blood-based gene expression profiles models for classification of subsyndromal symptomatic depression and major depressive disorder. PLoS One. 7:e312832012. View Article : Google Scholar : PubMed/NCBI

13 

Wei YC, Zhou FL, He DL, Bai JR, Hui LY, Wang XY and Nan KJ: The level of oxidative stress and the expression of genes involved in DNA-damage signaling pathways in depressive patients with colorectal carcinoma. J Psychosom Res. 66:259–266. 2009. View Article : Google Scholar : PubMed/NCBI

14 

Sourbier C, Ricketts CJ, Matsumoto S, Crooks DR, Liao PJ, Mannes PZ, Yang Y, Wei MH, Srivastava G, Ghosh S, et al: Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancer. Cancer Cell. 26:840–850. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Kolch W and Pitt A: Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nat Rev Cancer. 10:618–629. 2010. View Article : Google Scholar : PubMed/NCBI

16 

Lv B, Song C, Wu L, Zhang Q, Hou D, Chen P, Yu S, Wang Z, Chu Y, Zhang J, et al: Netrin-4 as a biomarker promotes cell proliferation and invasion in gastric cancer. Oncotarget. 6:9794–9806. 2015. View Article : Google Scholar : PubMed/NCBI

17 

Demitrack ES, Gifford GB, Keeley TM, Carulli AJ, VanDussen KL, Thomas D, Giordano TJ, Liu Z, Kopan R and Samuelson LC: Notch signaling regulates gastric antral LGR5 stem cell function. EMBO J. 34:2522–2536. 2015. View Article : Google Scholar : PubMed/NCBI

18 

Tavoli A, Mohagheghi MA, Montazeri A, Roshan R, Tavoli Z and Omidvari S: Anxiety and depression in patients with gastrointestinal cancer: Does knowledge of cancer diagnosis matter? BMC Gastroenterol. 7:282007. View Article : Google Scholar : PubMed/NCBI

19 

Shi M, Liu D, Duan H, Han C, Wei B, Qian L, Chen C, Guo L, Hu M, Yu M, et al: Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer. Mol Cancer. 9:2692010.PubMed/NCBI

20 

Audier AG: Determination of a constitutional neuroendocrine factor probably influencing tumor development in man: Prophylactic and therapeutic aspects. Cancer Detect Prev. 11:203–208. 1988.PubMed/NCBI

21 

Wei YC, Zhou FL, He DL, Bai JR, Ding H, Wang XY and Nan KJ: Oxidative stress in depressive patients with gastric adenocarcinoma. Int J Neuropsychopharmacol. 12:1089–1096. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Nordin K, Berglund G, Glimelius B and Sjödén PO: Predicting anxiety and depression among cancer patients: A clinical model. Eur J Cancer. 37:376–384. 2001. View Article : Google Scholar : PubMed/NCBI

23 

Hayakawa Y, Ariyama H, Stancikova J, Sakitani K, Asfaha S, Renz BW, Dubeykovskaya ZA, Shibata W, Wang H, Westphalen CB, et al: Mist1 expressing gastric stem cells maintain the normal and neoplastic gastric epithelium and are supported by a perivascular stem cell niche. Cancer Cell. 28:800–814. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Lim K, Hyun YM, Lambert-Emo K, Capece T, Bae S, Miller R, Topham DJ and Kim M: Neutrophil trails guide influenza-specific CD8+ T cells in the airways. Science. 349:aaa43522015. View Article : Google Scholar

25 

Finisguerra V, Di Conza G, Di Matteo M, Serneels J, Costa S, Thompson AA, Wauters E, Walmsley S, Prenen H, Granot Z, et al: MET is required for the recruitment of anti-tumoural neutrophils. Nature. 522:349–353. 2015. View Article : Google Scholar : PubMed/NCBI

26 

Harker JA, Lewis GM, Mack L and Zuniga EI: Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection. Science. 334:825–829. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Hodes GE, Kana V, Menard C, Merad M and Russo SJ: Neuroimmune mechanisms of depression. Nat Neurosci. 18:1386–1393. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Shi Q, Smith TG, Michonski JD, Stein KD, Kaw C and Cleeland CS: Symptom burden in cancer survivors 1 year after diagnosis: A report from the American Cancer Society's Studies of Cancer Survivors. Cancer. 117:2779–2790. 2011. View Article : Google Scholar : PubMed/NCBI

29 

Soubeyran P, Fonck M, Blanc-Bisson C, Blanc JF, Ceccaldi J, Mertens C, Imbert Y, Cany L, Vogt L, Dauba J, et al: Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol. 30:1829–1834. 2012. View Article : Google Scholar : PubMed/NCBI

30 

Liu Z, Zhang J, Yan J, Wang Y and Li Y: Leucocyte telomere shortening in relation to newly diagnosed type 2 diabetic patients with depression. Oxid Med Cell Longev. 2014:6739592014. View Article : Google Scholar : PubMed/NCBI

31 

Rybka J, Kędziora-Kornatowska K, Banaś-Leżańska P, Majsterek I, Carvalho LA, Cattaneo A, Anacker C and Kędziora J: Interplay between the pro-oxidant and antioxidant systems and proinflammatory cytokine levels, in relation to iron metabolism and the erythron in depression. Free Radic Biol Med. 63:187–194. 2013. View Article : Google Scholar : PubMed/NCBI

32 

Yang SL, Yu PL and Chung KR: The glutathione peroxidase-mediated reactive oxygen species resistance, fungicide sensitivity and cell wall construction in the citrus fungal pathogen Alternaria alternata. Environ Microbiol. 18:923–935. 2016. View Article : Google Scholar

33 

Bhattacharyya A, Chattopadhyay R, Mitra S and Crowe SE: Oxidative stress: An essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev. 94:329–354. 2014. View Article : Google Scholar : PubMed/NCBI

34 

Chan EC, Jiang F, Peshavariya HM and Dusting GJ: Regulation of cell proliferation by NADPH oxidase-mediated signaling: Potential roles in tissue repair, regenerative medicine and tissue engineering. Pharmacol Ther. 122:97–108. 2009. View Article : Google Scholar : PubMed/NCBI

35 

Wang H, Ma L, Li Y and Cho CH: Exposure to cigarette smoke increases apoptosis in the rat gastric mucosa through a reactive oxygen species-mediated and p53-independent pathway. Free Radic Biol Med. 28:1125–1131. 2000. View Article : Google Scholar : PubMed/NCBI

36 

Seo JS, Park JY, Choi J, Kim TK, Shin JH, Lee JK and Han PL: NADPH oxidase mediates depressive behavior induced by chronic stress in mice. J Neurosci. 32:9690–9699. 2012. View Article : Google Scholar : PubMed/NCBI

37 

Maes M, Galecki P, Chang YS and Berk M: A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry. 35:676–692. 2011. View Article : Google Scholar

38 

Holm F, Hellqvist E, Mason CN, Ali SA, Delos-Santos N, Barrett CL, Chun HJ, Minden MD, Moore RA, Marra MA, et al: Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal. Proc Natl Acad Sci USA. 112:15444–15449. 2015. View Article : Google Scholar : PubMed/NCBI

39 

Colicelli J: ABL tyrosine kinases: Evolution of function, regulation, and specificity. Sci Signal. 3:re62010. View Article : Google Scholar : PubMed/NCBI

40 

De Keersmaecker K, Rocnik JL, Bernad R, Lee BH, Leeman D, Gielen O, Verachtert H, Folens C, Munck S, Marynen P, et al: Kinase activation and transformation by NUP214-ABL1 is dependent on the context of the nuclear pore. Mol Cell. 31:134–142. 2008. View Article : Google Scholar : PubMed/NCBI

41 

Jabbour E, Kantarjian H, Ravandi F, Thomas D, Huang X, Faderl S, Pemmaraju N, Daver N, Garcia-Manero G, Sasaki K, et al: Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: A single-centre, phase 2 study. Lancet Oncol. 16:1547–1555. 2015. View Article : Google Scholar : PubMed/NCBI

42 

Greuber EK, Smith-Pearson P, Wang J and Pendergast AM: Role of ABL family kinases in cancer: From leukaemia to solid tumours. Nat Rev Cancer. 13:559–571. 2013. View Article : Google Scholar : PubMed/NCBI

43 

Deb S, Wong SQ, Li J, Do H, Weiss J, Byrne D, Chakrabarti A, Bosma T, Fellowes A, Dobrovic A, et al kConFab Investigators: Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations. Br J Cancer. 111:2351–2360. 2014. View Article : Google Scholar : PubMed/NCBI

44 

Cunningham JM, Vierkant RA, Sellers TA, Phelan C, Rider DN, Liebow M, Schildkraut J, Berchuck A, Couch FJ, Wang X, et al Ovarian Cancer Association Consortium: Cell cycle genes and ovarian cancer susceptibility: A tagSNP analysis. Br J Cancer. 101:1461–1468. 2009. View Article : Google Scholar : PubMed/NCBI

45 

Craig VJ, Cogliatti SB, Rehrauer H, Wündisch T and Müller A: Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis. Cancer Res. 71:3616–3624. 2011. View Article : Google Scholar : PubMed/NCBI

46 

Chiang YT, Yen YW and Lo CL: Reactive oxygen species and glutathione dual redox-responsive micelles for selective cytotoxicity of cancer. Biomaterials. 61:150–161. 2015. View Article : Google Scholar : PubMed/NCBI

47 

Müller A: Multistep activation of the Helicobacter pylori effector CagA. J Clin Invest. 122:1192–1195. 2012. View Article : Google Scholar : PubMed/NCBI

48 

Furlan A, Stagni V, Hussain A, Richelme S, Conti F, Prodosmo A, Destro A, Roncalli M, Barilà D and Maina F: Abl interconnects oncogenic Met and p53 core pathways in cancer cells. Cell Death Differ. 18:1608–1616. 2011. View Article : Google Scholar : PubMed/NCBI

49 

Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J and Malumbres M: Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell. 13:496–506. 2008. View Article : Google Scholar : PubMed/NCBI

50 

Faber J, Gregory RI and Armstrong SA: Linking miRNA regulation to BCR-ABL expression: The next dimension. Cancer Cell. 13:467–469. 2008. View Article : Google Scholar : PubMed/NCBI

51 

Park JH, Kim TY, Jong HS, Kim TY, Chun YS, Park JW, Lee CT, Jung HC, Kim NK and Bang YJ: Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1alpha in gastric cancer cells. Clin Cancer Res. 9:433–440. 2003.PubMed/NCBI

52 

Watson CJ, Collier P, Tea I, Neary R, Watson JA, Robinson C, Phelan D, Ledwidge MT, McDonald KM, McCann A, et al: Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype. Hum Mol Genet. 23:2176–2188. 2014. View Article : Google Scholar

53 

Frau M, Feo F and Pascale RM: Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis. J Hepatol. 59:830–841. 2013. View Article : Google Scholar : PubMed/NCBI

54 

Asimakopoulos FA, Shteper PJ, Krichevsky S, Fibach E, Polliack A, Rachmilewitz E, Ben-Neriah Y and Ben-Yehuda D: ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia. Blood. 94:2452–2460. 1999.PubMed/NCBI

55 

Sun B, Jiang G, Zaydan MA, La Russa VF, Safah H and Ehrlich M: ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors. Cancer Res. 61:6931–6937. 2001.PubMed/NCBI

56 

Hayashi Y, Bardsley MR, Toyomasu Y, Milosavljevic S, Gajdos GB, Choi KM, Reid-Lombardo KM, Kendrick ML, Bingener-Casey J, Tang CM, et al: Platelet-derived growth factor receptor-α regulates proliferation of gastrointestinal stromal tumor cells with mutations in KIT by stabilizing ETV1. Gastroenterology. 149:420–32.e16. 2015. View Article : Google Scholar

57 

Wu Z, Zhang Z, Ge X, Lin Y, Dai C, Chang J, Liu X, Geng R, Wang C, Chen H, et al: Identification of short-form RON as a novel intrinsic resistance mechanism for anti-MET therapy in MET-positive gastric cancer. Oncotarget. 6:40519–40534. 2015.PubMed/NCBI

58 

Javle M, Smyth EC and Chau I: Ramucirumab: Successfully targeting angiogenesis in gastric cancer. Clin Cancer Res. 20:5875–5881. 2014. View Article : Google Scholar : PubMed/NCBI

59 

Kuboki Y, Yamashita S, Niwa T, Ushijima T, Nagatsuma A, Kuwata T, Yoshino T, Doi T, Ochiai A and Ohtsu A: Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancer. Ann Oncol. 27:127–133. 2016. View Article : Google Scholar

60 

Lee J, Lee SE, Kang SY, Do IG, Lee S, Ha SY, Cho J, Kang WK, Jang J, Ou SH, et al: Identification of ROS1 rearrangement in gastric adenocarcinoma. Cancer. 119:1627–1635. 2013. View Article : Google Scholar : PubMed/NCBI

61 

Höcker M, Rosenberg I, Xavier R, Henihan RJ, Wiedenmann B, Rosewicz S, Podolsky DK and Wang TC: Oxidative stress activates the human histidine decarboxylase promoter in AGS gastric cancer cells. J Biol Chem. 273:23046–23054. 1998. View Article : Google Scholar : PubMed/NCBI

62 

Lorenz S, Deng P, Hantschel O, Superti-Furga G and Kuriyan J: Crystal structure of an SH2-kinase construct of c-Abl and effect of the SH2 domain on kinase activity. Biochem J. 468:283–291. 2015. View Article : Google Scholar : PubMed/NCBI

63 

Dölker N, Górna MW, Sutto L, Torralba AS, Superti-Furga G and Gervasio FL: The SH2 domain regulates c-Abl kinase activation by a cyclin-like mechanism and remodulation of the hinge motion. PLOS Comput Biol. 10:e10038632014. View Article : Google Scholar : PubMed/NCBI

64 

Thai M, Ting PY, McLaughlin J, Cheng D, Müschen M, Witte ON and Colicelli J: ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1. Leukemia. 25:290–300. 2011. View Article : Google Scholar :

65 

Chung KS, Han G, Kim BK, Kim HM, Yang JS, Ahn J, Lee K, Song KB and Won M: A novel antitumor piperazine alkyl compound causes apoptosis by inducing RhoB expression via ROS mediated c Abl/p38 MAPK signaling. Cancer Chemother Pharmacol. 72:1315–1324. 2013. View Article : Google Scholar : PubMed/NCBI

66 

Chen CC, Chu CB, Liu KJ, Huang CY, Chang JY, Pan WY, Chen HH, Cheng YH, Lee KD, Chen MF, et al: Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: The role of IL-6 signaling and Nrf2/AKR1C axis identification. Biochem Pharmacol. 86:872–887. 2013. View Article : Google Scholar : PubMed/NCBI

67 

Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P and Kensler TW: Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA. 98:3410–3415. 2001. View Article : Google Scholar : PubMed/NCBI

68 

Cai N, Bigdeli TB, Kretzschmar W, Li Y, Liang J, Song L, Hu J, Li Q, Jin W, Hu Z, et al CONVERGE consortium: Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature. 523:588–591. 2015. View Article : Google Scholar

69 

Nabavi SF, Bilotto S, Russo GL, Orhan IE, Habtemariam S, Daglia M, Devi KP, Loizzo MR, Tundis R and Nabavi SM: Omega-3 polyunsaturated fatty acids and cancer: Lessons learned from clinical trials. Cancer Metastasis Rev. 34:359–380. 2015. View Article : Google Scholar : PubMed/NCBI

70 

Cha EJ, Noh SJ, Kwon KS, Kim CY, Park BH, Park HS, Lee H, Chung MJ, Kang MJ, Lee DG, et al: Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma. Clin Cancer Res. 15:4453–4459. 2009. View Article : Google Scholar : PubMed/NCBI

71 

Xing R, Li W, Cui J, Zhang J, Kang B, Wang Y, Wang Z, Liu S and Lu Y: Gastrokine 1 induces senescence through p16/Rb pathway activation in gastric cancer cells. Gut. 61:43–52. 2012. View Article : Google Scholar

72 

Leto SM, Sassi F, Catalano I, Torri V, Migliardi G, Zanella ER, Throsby M, Bertotti A and Trusolino L: Sustained inhibition of HER3 and EGFR is necessary to induce regression of HER2-amplified gastrointestinal carcinomas. Clin Cancer Res. 21:5519–5531. 2015. View Article : Google Scholar : PubMed/NCBI

73 

Tu H, Sun H, Lin Y, Ding J, Nan K, Li Z, Shen Q and Wei Y: Oxidative stress upregulates PDCD4 expression in patients with gastric cancer via miR-21. Curr Pharm Des. 20:1917–1923. 2014. View Article : Google Scholar

74 

Ling M, Li Y, Xu Y, Pang Y, Shen L, Jiang R, Zhao Y, Yang X, Zhang J, Zhou J, et al: Regulation of miRNA-21 by reactive oxygen species-activated ERK/NF-κB in arsenite-induced cell transformation. Free Radic Biol Med. 52:1508–1518. 2012. View Article : Google Scholar : PubMed/NCBI

75 

Shi Z, Zhang J, Qian X, Han L, Zhang K, Chen L, Liu J, Ren Y, Yang M, Zhang A, et al: AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression. Cancer Res. 73:5519–5531. 2013. View Article : Google Scholar : PubMed/NCBI

76 

Albano F, Zagaria A, Anelli L, Coccaro N, Impera L, Minervini CF, Minervini A, Rossi AR, Tota G, Casieri P, et al: Gene expression profiling of chronic myeloid leukemia with variant t(9;22) reveals a different signature from cases with classic translocation. Mol Cancer. 12:362013. View Article : Google Scholar : PubMed/NCBI

77 

Kannan A, Krishnan A, Ali M, Subramaniam S, Halagowder D and Sivasithamparam ND: Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic condition. Eur J Cancer. 50:204–215. 2014. View Article : Google Scholar

78 

Rath S, Das L, Kokate SB, Pratheek BM, Chattopadhyay S, Goswami C, Chattopadhyay R, Crowe SE and Bhattacharyya A: Regulation of Noxa-mediated apoptosis in Helicobacter pylori-infected gastric epithelial cells. FASEB J. 29:796–806. 2015. View Article : Google Scholar

79 

Sumiyoshi Y, Kakeji Y, Egashira A, Mizokami K, Orita H and Maehara Y: Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer. Clin Cancer Res. 12:5112–5117. 2006. View Article : Google Scholar : PubMed/NCBI

80 

Hammond EM and Giaccia AJ: Hypoxia-inducible factor-1 and p53: Friends, acquaintances, or strangers? Clin Cancer Res. 12:5007–5009. 2006. View Article : Google Scholar : PubMed/NCBI

81 

Seok JK, Lee SH, Kim MJ and Lee YM: MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog. Nucleic Acids Res. 42:8062–8072. 2014. View Article : Google Scholar : PubMed/NCBI

82 

Humar B, Fukuzawa R, Blair V, Dunbier A, More H, Charlton A, Yang HK, Kim WH, Reeve AE, Martin I, et al: Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer. Cancer Res. 67:2480–2489. 2007. View Article : Google Scholar : PubMed/NCBI

83 

Bauer G, Bereswill S, Aichele P and Glocker E: Helicobacter pylori protects oncogenically transformed cells from reactive oxygen species-mediated intercellular induction of apoptosis. Carcinogenesis. 35:1582–1591. 2014. View Article : Google Scholar : PubMed/NCBI

84 

Mendes-da-Silva RF, Lopes-de-Morais AA, Bandim-da-Silva ME, Cavalcanti GA, Rodrigues AR, Andrade-da-Costa BL and Guedes RC: Prooxidant versus antioxidant brain action of ascorbic acid in well-nourished and malnourished rats as a function of dose: A cortical spreading depression and malondialdehyde analysis. Neuropharmacology. 86:155–160. 2014. View Article : Google Scholar : PubMed/NCBI

85 

Bolton-Gillespie E, Schemionek M, Klein HU, Flis S, Hoser G, Lange T, Nieborowska-Skorska M, Maier J, Kerstiens L, Koptyra M, et al: Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells. Blood. 121:4175–4183. 2013. View Article : Google Scholar : PubMed/NCBI

86 

Wei J, O'Brien D, Vilgelm A, Piazuelo MB, Correa P, Washington MK, El-Rifai W, Peek RM and Zaika A: Interaction of Helicobacter pylori with gastric epithelial cells is mediated by the p53 protein family. Gastroenterology. 134:1412–1423. 2008. View Article : Google Scholar : PubMed/NCBI

87 

Bertotti A, Bracco C, Girolami F, Torti D, Gastaldi S, Galimi F, Medico E, Elvin P, Comoglio PM and Trusolino L: Inhibition of Src impairs the growth of met-addicted gastric tumors. Clin Cancer Res. 16:3933–3943. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Huang T, Zhou F, Wang‑Johanning F, Nan K and Wei Y: Depression accelerates the development of gastric cancer through reactive oxygen species‑activated ABL1 (Review). Oncol Rep 36: 2435-2443, 2016.
APA
Huang, T., Zhou, F., Wang‑Johanning, F., Nan, K., & Wei, Y. (2016). Depression accelerates the development of gastric cancer through reactive oxygen species‑activated ABL1 (Review). Oncology Reports, 36, 2435-2443. https://doi.org/10.3892/or.2016.5127
MLA
Huang, T., Zhou, F., Wang‑Johanning, F., Nan, K., Wei, Y."Depression accelerates the development of gastric cancer through reactive oxygen species‑activated ABL1 (Review)". Oncology Reports 36.5 (2016): 2435-2443.
Chicago
Huang, T., Zhou, F., Wang‑Johanning, F., Nan, K., Wei, Y."Depression accelerates the development of gastric cancer through reactive oxygen species‑activated ABL1 (Review)". Oncology Reports 36, no. 5 (2016): 2435-2443. https://doi.org/10.3892/or.2016.5127
Copy and paste a formatted citation
x
Spandidos Publications style
Huang T, Zhou F, Wang‑Johanning F, Nan K and Wei Y: Depression accelerates the development of gastric cancer through reactive oxygen species‑activated ABL1 (Review). Oncol Rep 36: 2435-2443, 2016.
APA
Huang, T., Zhou, F., Wang‑Johanning, F., Nan, K., & Wei, Y. (2016). Depression accelerates the development of gastric cancer through reactive oxygen species‑activated ABL1 (Review). Oncology Reports, 36, 2435-2443. https://doi.org/10.3892/or.2016.5127
MLA
Huang, T., Zhou, F., Wang‑Johanning, F., Nan, K., Wei, Y."Depression accelerates the development of gastric cancer through reactive oxygen species‑activated ABL1 (Review)". Oncology Reports 36.5 (2016): 2435-2443.
Chicago
Huang, T., Zhou, F., Wang‑Johanning, F., Nan, K., Wei, Y."Depression accelerates the development of gastric cancer through reactive oxygen species‑activated ABL1 (Review)". Oncology Reports 36, no. 5 (2016): 2435-2443. https://doi.org/10.3892/or.2016.5127
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team